Mathew Peterson

Title: Mathew Peterson: Innovator in Pharmaceutical Compositions

Introduction

Mathew Peterson is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurodegenerative and neurodevelopmental disorders. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.

Latest Patents

Mathew's latest patents focus on the compositions of trofinetide. These disclosures describe compounds of Formula (I), including stereoisomers and side compounds. The patents detail pharmaceutical compositions and methods of manufacturing these compounds using silylation reagents. More specifically, they outline the manufacture of trofinetide and its side products, as well as the compositions and products containing these compounds for pharmaceutical uses.

Career Highlights

Mathew Peterson is currently associated with Neuren Pharmaceuticals Limited, where he continues to innovate in the pharmaceutical sector. His work is pivotal in advancing treatments for various neurological conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Mathew collaborates with esteemed colleagues such as Clive Blower and James Murray Shaw. Their combined expertise enhances the research and development efforts at Neuren Pharmaceuticals Limited.

Conclusion

Mathew Peterson's contributions to pharmaceutical innovations, particularly in the area of neurodegenerative disorders, highlight his role as a key inventor in the field. His patents and collaborations reflect a dedication to advancing medical science and improving lives through innovative solutions.